UMB Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

UMB Bank’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1,003	Closed	-$31.5K	–	2302
2026 Q2	$31.5K	Buy	1,003 +322	+47%	+$9.5K	﹤0.01%	1501
2026 Q1	$16.9K	Buy	681 +91	+15%	+$2.17K	﹤0.01%	1665
2025 Q4	$13.8K	Buy	590 +160	+37%	+$3.56K	﹤0.01%	1692
2025 Q3	$8.47K	Buy	430 +3	+0.7%	+$62	﹤0.01%	1742
2025 Q2	$9.27K	Buy	427 +10	+2%	+$236	﹤0.01%	1629
2025 Q1	$10.1K	Buy	417 +135	+48%	+$3.04K	﹤0.01%	1545
2024 Q4	$5.88K	Hold	282	–	–	﹤0.01%	1652
2024 Q3	$5.61K	Buy	282 +140	+99%	+$2.6K	﹤0.01%	1690
2024 Q2	$2.2K	Buy	142 +92	+184%	+$1.43K	﹤0.01%	1740
2024 Q1	$797	Buy	+50	New	+$753	﹤0.01%	1850

Other funds holding CPRX

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

UMB Bank's CPRX Position: Q3 2026 in Review

UMB Bank sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 1,003 shares — an estimated $31.5K sold.

UMB Bank first reported a position in CPRX in Q1 2024 and held it in 10 quarters. The position peaked at $31.5K in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

UMB Bank reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
UMB Bank sold 1,003 Catalyst Pharmaceutical shares in Q3 2026, an estimated $31.5K.
UMB Bank first reported a position in Catalyst Pharmaceutical in Q1 2024 and held it in 10 quarters.
UMB Bank's Catalyst Pharmaceutical position peaked at $31.5K in Q2 2026.
2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on UMB Bank's 13F filing for Q3 2026, filed 6 Nov 2026.